P. Yalamanchili

发表

Poliovirus 3C protease-mediated degradation of transcriptional activator p53 requires a cellular activity.

M. Weidman, P. Yalamanchili, B. Ng, 2001, Virology.

Design, synthesis, and evaluation of radiolabeled integrin αvβ3 receptor antagonists for tumor imaging and radiotherapy

S. Robinson, P. Yalamanchili, T. Harris, 2003 .

Radiolabeled divalent peptidomimetic vitronectin receptor antagonists as potential tumor radiotherapeutic and imaging agents.

R. Sachleben, P. Yalamanchili, S. Robinson, 2007, Bioconjugate chemistry.

Noninvasive Targeted Imaging of Matrix Metalloproteinase Activation in a Murine Model of Postinfarction Remodeling

D. Dione, A. Sinusas, L. Dobrucki, 2005, Circulation.

Effects of Picornavirus Proteinases on Host Cell Transcription

S. Kliewer, A. Berk, Saumitra Das, 2002 .

Poliovirus-encoded protease 2APro cleaves the TATA-binding protein but does not inhibit host cell RNA polymerase II transcription in vitro

P. Yalamanchili, A. Dasgupta, R. Banerjee, 1997, Journal of virology.

Detection of Injury-Induced Vascular Remodeling by Targeting Activated &agr;vβ3 Integrin In Vivo

A. Sinusas, B. Zaret, P. Yalamanchili, 2004 .

Effect of LX 4211 on Glucose Homeostasis and Body Composition in Preclinical Models s

Alan G. E. Wilson, F. Mseeh, Z. Ding, 2014 .

Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy.

N. Wong, N. Narula, P. Yalamanchili, 2008, Journal of the American College of Cardiology.

Synthesis and Cardiac Imaging of (18)F-Ligands Selective for β1-Adrenoreceptors.

P. Yalamanchili, S. Robinson, T. Harris, 2011, ACS medicinal chemistry letters.

Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo.

A. Sinusas, B. Zaret, P. Yalamanchili, 2004, Circulation.

Evaluation of LMI1195, a Novel 18F-Labeled Cardiac Neuronal PET Imaging Agent, in Cells and Animal Models

S. Robinson, P. Yalamanchili, J. Lazewatsky, 2011, Circulation. Cardiovascular imaging.

Evaluation of LMI 1195 , a Novel 18 F-Labeled Cardiac Neuronal PET Imaging Agent , in Cells and Animal Models

S. Robinson, P. Yalamanchili, J. Lazewatsky, 2011 .

Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents.

P. Yalamanchili, S. Robinson, Shuang Liu, 2006, Bioconjugate chemistry.

Abstract 1914: BMS753951: A Novel Low Molecular Weight Magnetic Resonance Contrast Agent Selective For Arterial Wall Imaging

S. Robinson, P. Yalamanchili, T. Harris, 2007 .

Cardiac imaging and uptake mechanism of 18F LMI1195, a novel PET cardiac neuronal imaging agent

P. Yalamanchili, S. Robinson, M. Azure, 2010 .

Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy.

P. Yalamanchili, S. Robinson, T. Harris, 2003, Cancer biotherapy & radiopharmaceuticals.

Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932).

Alan G. E. Wilson, W. K. Sonnenburg, D. Augeri, 2010, Journal of medicinal chemistry.

Amino Acid derived enamides: synthesis and aminopeptidase activity.

P. Yalamanchili, R. Cesati, D. Casebier, 2007, Organic letters.

Synthesis and biological evaluation of pyridazinone analogues as potential cardiac positron emission tomography tracers.

S. Robinson, P. Yalamanchili, A. Purohit, 2008, Journal of medicinal chemistry.

Mechanism of uptake and retention of F-18 BMS-747 158-02 in cardiomyocytes: a novel PET myocardial imaging agent

S. Robinson, P. Yalamanchili, A. Purohit, 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Definition of EGF-like, closely interacting modules that bear activation epitopes in integrin β subunits

S. Blacklow, J. Takagi, T. Springer, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Cleavage of transcriptional activator Oct-1 by poliovirus encoded protease 3Cpro.

P. Yalamanchili, A. Dasgupta, A Dasgupta, 1997, Virology.

Inhibition of basal transcription by poliovirus: a virus- encoded protease (3Cpro) inhibits formation of TBP-TATA box complex in vitro

E. Wimmer, P. Yalamanchili, A. Dasgupta, 1996, Journal of virology.

Folding and Function of I Domain-deleted Mac-1 and Lymphocyte Function-associated Antigen-1*

T. Springer, Chafen Lu, C. Oxvig, 2000, The Journal of Biological Chemistry.

Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus-encoded protease 3Cpro

P. Yalamanchili, A. Dasgupta, U. Datta, 1997, Journal of virology.

DNA binding domain and subunit interactions of transcription factor IIIC revealed by dissection with poliovirus 3C protease

A. Berk, P. Yalamanchili, A. Dasgupta, 1996, Molecular and cellular biology.

AAV2-hAADC (Eladocagene Exuparvovec) Biodistribution and Expression: Superiority of Intraputaminal versus Intracerebroventricular and Intrathecal (Lumbar) Routes of Administration

P. Yalamanchili, S. DeMarco, D. R. Compton, 2022, International journal of toxicology.

Assessment of 18F-labeled mitochondrial complex I inhibitors as PET myocardial perfusion imaging agents in rats, rabbits, and primates

S. Robinson, P. Yalamanchili, A. Purohit, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Effect of LX4211 on Glucose Homeostasis and Body Composition in Preclinical Models

Alan G. E. Wilson, F. Mseeh, Z. Ding, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Synthesis and biological evaluation of the mitochondrial complex 1 inhibitor 2-[4-(4-fluorobutyl)benzylsulfanyl]-3-methylchromene-4-one as a potential cardiac positron emission tomography tracer.

S. Robinson, P. Yalamanchili, M. Azure, 2007, Journal of Medicinal Chemistry.

Effect of LX4211 on Glucose Homeostasis and Body Composition in Preclinical Models

F. Mseeh, P. Yalamanchili, A. Nouraldeen, 2014 .